A covariate-adjusted adaptive design for two-stage clinical trials with survival data

Statistica Neerlandica

Volumn 64, Issue 2, 2010, Pages 202-226

  Bandyopadhyay, Uttam ^a   Biswas, Atanu ^b   Bhattacharya, Rahul ^c  

^a UNIVERSITY OF CALCUTTA   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

^c WEST BENGAL STATE UNIVERSITY   (India)

Author keywords

Censoring; Covariate adjusted adaptive allocation; Ethics; Optimality; Survival data

Indexed keywords

EID: 77952807905     PISSN: 00390402     EISSN: 14679574     Source Type: Journal    
DOI: 10.1111/j.1467-9574.2010.00451.x     Document Type: Article

References (60)

1. Abdushukorov A A. On some estimates of the distribution function under random censorship. Conference of Young Scientists 1984, in, Mathematical Institute of Acadamical Science Uzbek SSR, Tashkent, VINITI No. 8756-V (in Russian)
2. Atkinson A C, Biswas A. Bayesian adaptive biased coin design for sequential clinical trials. Biometrics 2004, 61:118-125.
3. Atkinson A C, Biswas A. Adaptive biased-coin designs for skewing the allocation proportion in clinical trials with normal responses. Statistics in Medicine 2005, 24:2477-2492.
4. Atkinson A C, Donev A N. Optimum experimental designs 1996, Oxford University Press, Oxford
5. Ball F G, Smith A F M, Verdinelli I. Biased coin designs with a Bayesian bias. Journal of Statistical Planning and Inference 1993, 34:403-421.
6. Bandyopadhyay U, Biswas A. Adaptive designs for normal responses with prognostic factors. Biometrika 2001, 88:409-419.
7. Bauer M, Bauer P, Buddle M. A simulation program for adaptive two stage designs. Computational Statistics & Data Analysis 1994, 26:351-371.
8. Bauer P, Brannath W, Posch M. Flexible two-stage designs: an overview. Methods of Information in Medicine 2001, 40:117-121.
9. Chen C H. A correlation goodness-of-fit test for randomly censored data. Biometrika 1984, 71:315-322.
10. Chen Y Y, Hollander M, Langberg N A. Small-sample results for the Kaplan-Meier estimator. Journal of the American Statistical Association 1982, 77:141-144.
11. Cheng C H, Lin G D. Maximum likelihood estimation of a survival function under the Kojiol-Green proportional hazards model. Statistics & Probability Letters 1987, 5:75-80.
12. Cheung Y K, Thall P F. Monitoring the rates of composite events with censored data in phase I clinical trials. Biometrics 2002, 58:89-97.
13. Coad D S. Some results on estimation for two stage clinical trials. Sequential Analysis 1992, 11:299-311.
14. Coad D S. Sequential estimation for two-stage and three-stage clinical trials. Journal of Statistical Planning and Inference 1994, 43:343-351.
15. Cox D R. The analysis of exponentially distributed life-times with two types of failure. Journal of the Royal Statistical Society Series B 1959, 21:411-421.
16. Cox D R, Snell E J. A general definition of residuals. Journal of the Royal Statistical Society Series B 1968, 30:248-275.
17. Csorgo S. Testing the proportional hazards model of random censorship. Proceedings of the Fourth Prague Symposium on Asymptotic Statistics 1989, 41-53. Mandl PHuskova M. in, eds, Charles University Press, Prague, pp
18. Csorgo S, Horvath L. On the Koziol-Green model for random censorship. Biometrika 1981, 68:391-401.
19. Dauxois J-Y, Kirmani S N U A. On testing the proportionality of two cumulative incidence functions in a competing risks setup. Nonparametric Statistics 2003, 16:479-491.
20. De una-alvarez J, Gonzalez-manteiga W. Distributional convergence under proportional censorship when covariates are present. Statistics & Probability Letters 1998, 39:305-315.
21. De una-alvarez J, Gonzalez-manteiga W. Strong consistency under proportional censorship when covariates are present. Statistics & Probability Letters 1999, 42:283-292.
22. Ebrahimi N. Nonparametric estimation of survival functions for incomplete observations when the life time distribution is proportionally related to the censoring time distribution. Communications in Statistics: Theory and Methods 1985, 14:2887-2898.
23. Ebrahimi N, Habibullah M. Testing to determine the underlying distribution using incomplete observations when the life time distribution is proportionally related to the censoring time distribution. Journal of Statistical Computation and Simulation 1992, 40:109-118.
24. Feigl P, Zelen M. Estimation of exponential survival probabilities with concomitant information. Biometrics 1965, 21:826-838.
25. Gather U, Pawlitschko J. Estimating the survival function under a generalized Koziol-Green model with partially informative censoring. Metrika 1998, 48:189-207.
26. Ghorai J K. Estimation of a smooth quantile function under the proportional hazards model. Annals of the Institute of Statistical Mathematics 1991, 43:747-760.
27. Gijbels I, Veraverbeke N. Quantile estimation in the proportion hazards model of random censorship. Communications in Statistics: Theory and Methods 1989, 18:1645-1663.
28. Glaser M. Exponential survival with covariance. Journal of the American Statistical Association 1967, 62:561-568.
29. Gnedenko BV. The theory of probability 1962, Chelsea, New York
30. Hajek J, Sidak Z. Theory of Rank Tests 1967, Academic Press, New York
31. Henze N. A quick omnibus test for the proportional hazards model of random censorship. Statistics 1993, 24:253-263.
32. Herbst T. Test of fit with the Kojiol-Green model for random censorship. Statistics and Decisions 1992, 10:163-171.
33. Hollander M, Proschan F. Testing to determine the underlying distribution using randomly censored data. Biometrics 1979, 35:393-401.
34. Jennison C, Turnbull B W. Group sequential methods with applications to clinical trials 2000, Chapman & Hall, Boca Raton, FL
35. Kalbfleisch J D, Prentice R L. The statistical analysis of failure time data 2002, Wiley Interscience, New York
36. Koziol J A, Green S B. A Cramer-Von Mises statistic for randomly censored data. Biometrika 1976, 63:465-474.
37. Lawless J F. Confidence interval estimation in the inverse power law model. Applied Statistics 1976, 25:128-138.
38. Lawrence J. Strategies for changing the test statistic during a clinical trial. Journal of Biopharmaceutical Statistics 2002, 12:193-205.
39. Liu Q, Chi G Y. On sample size and inference for two-stage adaptive designs. Biometrics 2001, 57:172-177.
40. Liu Q, Proschan M A, Pledger G W. A unified theory of two-stage adaptive designs. Journal of the American Statistical Association 2002, 97:1034-1041.
41. Matthews J NS. An introduction to randomized controlled clinical trials 2000, Edward Arnold, London
42. Pawlitschko J. A comparison of survival function estimators in the Kojiol-Green model. Statistics 1999, 32:277-291.
43. Posch M, Bauer P. Adaptive two stage designs and the conditional error function. Biometrical Journal 1999, 41:689-696.
44. Prentice R L. Exponential survival with censoring and explanatory variables. Biometrika 1973, 61:539-544.
45. Proschan M A, Hunsberger S A. Designed extension of studies based on conditional power. Biometrics 1995, 51:1315-1324.
46. Proschan M A, Liu Q, Hunsberger S. Practical midcourse sample size modification in clinical trials. Controlled Clinical Trials 2003, 24:4-15.
47. Rao C R. Linear statistical inference and its applications 1973, Wiley, New York
48. Rosenberger W F, Lachin J L. Randomisation in clinical Trials: Theory and Practice 2002, Wiley, New York
49. Rosenberger WF, Seshaiyer P. Adaptive survival trials. Journal of Biopharmaceutical Statistics 1997, 7:617-624.
50. Shao J. Mathematical statistics 1999, Springer-Verlag, New York
51. Stute W. Strong consistency under the Kojiol-Green model. Statistics & Probability Letters 1992, 14:313-320.
52. Subramanian S. Efficient estimation of regression coefficients and baseline hazard under proportionality of conditional hazard. Journal of Statistical Planning and Inference 2000, 84:81-94.
53. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Journal of the American Medical Association 1992, 267:1213-1220.
54. Veraverbeke N, Cdarso-suarez C. Estimation of the conditional distribution in a conditional Kojiol-Green model. Test 2000, 9:97-122.
55. Ware J H. Investigating therapies of potentially great benefit: ECMO. Statistical Science 1989, 4:298-340.
56. Zelen M. Factorial experiments in life testing. Technometrics 1959, 1:269-288.
57. Zeymer U, Suryapranata H, Monassier J P, Opolski G, Davies J, Rasmanis G, Linssen G, Tebbe U, Schroder R, Tiemann R, Machnig T, Neuhaus K-L. The Na+/H+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infraction. Journal of the American College of Cardiology 2001a, 38:1644-1651. for the ESCAMI Investigators
58. Zeymer U, Suryapranata H, Monassier J P, Opolski G, Davies J, Rasmanis G, Linsen G, Tebbe U, Schroder R, Willberg M L, Tiemann R, Maching T, Neuhaus K-L. Evaluation of the safety and cardioprotective effects of eniporide, a specific sodium/hydrogen exchange inhibitor, given as adjunctive therapy to reperfusion in patients with acute myocardial infraction. Heart Drug 2001b, 1:71-76.
59. Zheng G, Gastwirth J L. On the Fisher information in randomly censored data. Statistics & Probability Letters 2001, 52:421-426.
60. Zheng G, Gastwirth J L. Fisher information in ordered randomly censored data with applications to characterization problems. Statistica Sinica 2003, 13:507-517.